A prospective clinical and transcriptomic feasibility study of oral‐only hormonal therapy with radiation for unfavorable prostate cancer in men 70 years of age and older or with comorbidity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A prospective clinical and transcriptomic feasibility study of oral‐only hormonal therapy with radiation for unfavorable prostate cancer in men 70 years of age and older or with comorbidity

Published:2021-04-21 Issue:15 Volume:127 Page:2631-2640
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Onderdonk Benjamin E.¹^ORCID,Dorn Paige L.²,Martinez Carlos¹,Arif Fauzia¹,Cloutier Denise¹,Antic Tatjana³,Golden Daniel W.¹^ORCID,Karrison Theodore⁴,Pitroda Sean P.¹,Szmulewitz Russell Z.⁵,Liauw Stanley L.¹^ORCID

Affiliation:

1. Department of Radiation and Cellular Oncology University of Chicago Medicine Chicago Illinois

2. Rose Medical Center Radiation Oncology Denver Colorado

3. Department of Pathology University of Chicago Medicine Chicago Illinois

4. Department of Biostatistics University of Chicago Medicine Chicago Illinois

5. Department of Medicine University of Chicago Medicine Chicago Illinois

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33556

Reference34 articles.

1. The use of Hormonal Therapy to Augment Radiation Therapy in Prostate Cancer: An Update

2. Adverse Effects of Androgen Deprivation Therapy: Defining the Problem and Promoting Health Among Men with Prostate Cancer

3. Challenges of managing elderly men with prostate cancer

4. Androgen Suppression and Radiation vs Radiation Alone for Prostate Cancer

5. A Nomogram for Testosterone Recovery After Combined Androgen Deprivation and Radiation Therapy for Prostate Cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormonal Therapy and Radiation Therapy in Prostate Cancer: 5-Year Outcomes From a Trial Evaluating Combined Androgen Blockade With 5-Alpha Reductase Inhibitors as an Alternative to Gonadotropin Releasing Hormone Agonists;Clinical Genitourinary Cancer;2024-08

2. Therapeutic effects of finasteride: inhibition of disease progression and serum prostate-specific antigen reduction in patients with prostatic intraepithelial neoplasia;Annales de Biologie Clinique;2023-12

3. A Liquid–Liquid Phase Separation-Related Index Associate with Biochemical Recurrence and Tumor Immune Environment of Prostate Cancer Patients;International Journal of Molecular Sciences;2023-03-14

4. The Clinical Utility of Systemic Immune-Inflammation Index Supporting Charlson Comorbidity Index and CAPRA-S Score in Determining Survival after Radical Prostatectomy—A Single Centre Study;Cancers;2022-08-26

5. Novel forms of prostate cancer chemoresistance to successful androgen deprivation therapy demand new approaches: Rationale for targeting BET proteins;The Prostate;2022-04-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3